Neuralink Receives FDA Approval for Human Brain Implant Study
Elon Musk's Neuralink has received FDA approval to conduct its first human tests for its brain-chip implant technology, which aims to help restore people's vision and mobility by connecting brains with computers. The microchips are designed to interpret signals produced in the brain and relay information to devices via Bluetooth. Neuralink hopes to use its technology to treat conditions such as paralysis and blindness, and to help certain disabled people use computers and mobile technology. The company has repeatedly overestimated the speed at which it can execute its plans, but promises that "safety, accessibility and reliability" are all priorities during its engineering process.